- All regions
- Asia
Hong Kong
India
Japan
Korea, Republic of
Singapore
Taiwan- Australasia
Australia
New Zealand- Europe
Austria
Belgium
Bosnia Herzegovina
Bulgaria
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Serbia Montenegro
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom- North America
Canada
United States
Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
| Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
|---|---|---|---|
 CAPRCapricor Therapeutics | $1.67bn | n/a | n/a |
| NUVBNuvation Bio | $1.65bn | n/a | n/a |
| PVLAPalvella Therapeutics | $1.63bn | n/a | n/a |
| RXRXRecursion Pharmaceuticals | $1.60bn | n/a | n/a |
| ATAIAtaiBeckley | $1.59bn | n/a | n/a |
| GLUEMonte Rosa Therapeutics | $1.59bn | n/a | n/a |
| IMTXImmatics NV | $1.59bn | n/a | n/a |
| ABCLAbCellera Biologics | $1.59bn | n/a | n/a |
| TSHATaysha Gene Therapies | $1.58bn | n/a | n/a |
| DMRADamora Therapeutics | $1.56bn | n/a | n/a |
| VIRVir Biotechnology | $1.55bn | n/a | n/a |
| QUREUniqure NV | $1.53bn | n/a | n/a |
| GHRSGH Research | $1.52bn | n/a | n/a |
| MBXMBX Biosciences | $1.52bn | n/a | n/a |
| NVAXNovavax | $1.51bn | 679.2 | n/a |
| AMLXAmylyx Pharmaceuticals | $1.51bn | n/a | n/a |
| ARDXArdelyx | $1.51bn | n/a | n/a |
| INBXInhibrx Biosciences | $1.49bn | n/a | n/a |
| SLSSellas Life Sciences | $1.45bn | n/a | n/a |
| MAZEMaze Therapeutics | $1.43bn | n/a | n/a |